Literature DB >> 7913101

Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.

D C Mangham1, D C Rowlands, K M Newbold, G M Reynolds, J W Fielding, M T Hallissey.   

Abstract

It has been proposed that immunostaining with PC10, a monoclonal antibody against proliferating cell nuclear antigen (PCNA), is of prognostic value in gastric carcinoma. Gastric carcinomas from a series of 90 patients in whom survival data were known have been studied. There was no relation between the degree of PC10 immunostaining assessed semiquantitatively and survival.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913101      PMCID: PMC502033          DOI: 10.1136/jcp.47.5.473

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  The complexities of proliferating cell nuclear antigen.

Authors:  D McCormick; P A Hall
Journal:  Histopathology       Date:  1992-12       Impact factor: 5.087

2.  A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction.

Authors:  R J Scott; P A Hall; J S Haldane; S van Noorden; Y Price; D P Lane; N A Wright
Journal:  J Pathol       Date:  1991-10       Impact factor: 7.996

3.  Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA).

Authors:  C C Yu; P A Hall; C D Fletcher; R S Camplejohn; N H Waseem; D P Lane; D A Levison
Journal:  Histopathology       Date:  1991-07       Impact factor: 5.087

4.  Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.

Authors:  S Jain; M I Filipe; P A Hall; N Waseem; D P Lane; D A Levison
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

5.  The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens.

Authors:  D McCormick; C Yu; C Hobbs; P A Hall
Journal:  Histopathology       Date:  1993-06       Impact factor: 5.087

6.  Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy.

Authors:  Y Yonemura; H Kimura; S Fushida; K Tugawa; Y Nakai; M Kaji; L Fonseca; A Yamaguchi; I Miyazaki
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

7.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

Authors:  P A Hall; D A Levison; A L Woods; C C Yu; D B Kellock; J A Watkins; D M Barnes; C E Gillett; R Camplejohn; R Dover
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

8.  A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.

Authors:  C C Yu; C D Fletcher; P L Newman; J R Goodlad; J C Burton; D A Levison
Journal:  J Pathol       Date:  1992-02       Impact factor: 7.996

9.  Measurement of cell proliferation in gastric carcinoma: comparative analysis of Ki-67 and proliferative cell nuclear antigen (PCNA).

Authors:  J C Rosa; R Mendes; M I Filipe; R W Morris
Journal:  Histochem J       Date:  1992-02

10.  Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form.

Authors:  N H Waseem; D P Lane
Journal:  J Cell Sci       Date:  1990-05       Impact factor: 5.285

  10 in total
  4 in total

1.  Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.

Authors:  G O Elpek; T Gelen; N H Aksoy; T Karpuzoglu; N Keles
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  The abundance of Rad51 protein in mouse embryonic stem cells is regulated at multiple levels.

Authors:  Elisia D Tichy; Resmi Pillai; Li Deng; Jay A Tischfield; Philip Hexley; George F Babcock; Peter J Stambrook
Journal:  Stem Cell Res       Date:  2012-05-22       Impact factor: 2.020

3.  High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.

Authors:  Hua-Rong Tang; Xian-Qin Luo; Gang Xu; Yan Wang; Zhi-Jun Feng; Hui Xu; Ya-Wei Shi; Qin Zhang; Li-Guang Wu; Chun-Quan Xue; Cheng-Wei Wang; Chao-Yang Wu
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

4.  Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis.

Authors:  Songcheng Yin; Zhan Li; Jinyu Huang; Zhifeng Miao; Junyan Zhang; Chunyang Lu; Hao Xu; Huimian Xu
Journal:  Onco Targets Ther       Date:  2017-01-10       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.